Representative before the EPO

Employment test 51 - 200 employees
Company dna venner shipley llp
operating since 1947
Headquarter in London and 5 offices
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 501 - 1000 employees
Company dna mintz levin cohn ferris glovsky and popeo pc
operating since 1933
Headquarter in Boston and 9 offices
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 51 - 200 employees
Company dna haseltine lake llp
no operation time available
Headquarter in Bristol and 7 offices
active in Legal Services and IP Consulting

We have observed 49 EP applications Isobel Lara Finnie has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 06, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12854522

PERSONALIZED PAIN MANAGEMENT AND ANESTHESIA: PREEMPTIVE RISK IDENTIFICATION AND THERAPEUTIC DECISION SUPPORT

IPC classification:
C12Q 1/68, C12N 15/12, C12N 15/11, C07K 7/06
Applicant:
Children's Hospital Medical Center
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13747279

A MULTI-BIOMARKER-BASED OUTCOME RISK STRATIFICATION MODEL FOR PEDIATRIC SEPTIC SHOCK

IPC classification:
G01N 33/68, G01N 33/50, C40B 30/00, C12Q 1/68
Applicant:
Children's Hospital Medical Center
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Regina Neuefeind, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP13746458

A MULTI-BIOMARKER-BASED OUTCOME RISK STRATIFICATION MODEL FOR ADULT SEPTIC SHOCK

IPC classification:
G01N 33/68, G01N 33/53, G01N 33/50
Applicant:
Children's Hospital Medical Center
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Regina Neuefeind, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP13751420

ESOPHAGEAL MICRORNA EXPRESSION PROFILES IN EOSINOPHILIC ESOPHAGITIS

IPC classification:
C12Q 1/68, C12N 15/11
Applicant:
Children's Hospital Medical Center
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Regina Neuefeind, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14189758

Antibodies directed to GPNMB and uses thereof

IPC classification:
A61K 47/48, A61K 39/395, A61K 39/00, C07K 16/30, C07K 16/28, A61P 35/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Isobel Lara Finnie, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
EXAMINATION IN PROGRESS
EP13798097

FREEZE-DRYING CONJUGATE-CONSTRUCT FOR POINT-OF-CARE TESTING IMMUNOCHROMATOGRAPHY, A KIT FOR IMMUNOASSAY USING THE SAME, AND A METHOD FOR ANALYSIS USING THE KIT

IPC classification:
G01N 33/538, G01N 33/532, G01N 33/53, G01N 30/02
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Isobel Lara Finnie, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
EXAMINATION IN PROGRESS
EP13742640

QUINONE COMPOUNDS AND THEIR USES FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/495, C07D 403/10, A61P 35/00
Agent:
Multiple attorneys, Haseltine Lake LLP
Agent:
Isobel Lara Finnie, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
The patent has been granted
EP13786660

BIOMARKER COMBINATIONS FOR COLORECTAL TUMORS

IPC classification:
C12Q 1/68
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Isobel Lara Finnie, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
EXAMINATION IN PROGRESS
EP14748796

BIODEGRADABLE AND CLINICALLY-COMPATIBLE NANOP ARTICLES AS DRUG DELIVERY CARRIERS

IPC classification:
A61K 47/48, C07H 21/02, A61K 48/00, A61K 47/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Nathan Joel Hinks, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14757651

METHODS OF TREATING OTOTOXICITY

IPC classification:
A61K 31/202
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14716187

SYSTEMS FOR SUSTAINED INTRAOCULAR DELIVERY OF LOW SOLUBILITY COMPOUNDS FROM A PORT DELIVERY SYSTEM IMPLANT

IPC classification:
A61K 9/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Catherine Louise Booth, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14721620

3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/433, C07D 487/04, C07D 471/04, C07D 417/14, C07D 417/04, C07D 409/14, C07D 403/14, C07D 403/06, C07D 413/14, C07D 405/14, C07D 401/14
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14728712

BIMATOPROST OCULAR SILICONE INSERTS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/5575, A61K 9/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Catherine Louise Booth, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15189243

ANTIBODIES AGAINST T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN 1 (TIM-1) ANTIGEN AND USES THEREOF

IPC classification:
A61P 35/00, C07K 16/18, C07K 14/47, C12N 15/12
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14742552

TUMOUR-TARGETED THERANOSTIC

IPC classification:
A61K 49/18, A61K 47/48
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Applicant:
The University of Bradford
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14832137

IDENTIFICATION OF SURGERY CANDIDATES USING NATURAL LANGUAGE PROCESSING

IPC classification:
G06Q 50/24, G06F 17/30
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14790002

DEVICE

IPC classification:
A61F 13/15, A61L 15/22
Agent:
Kevin John Cordina, Simmons & Simmons LLP
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP16156340

COMPOSITIONS OF KINASE INHIBITORS AND THEIR USE FOR TREATMENT OF CANCER AND OTHER DISEASES RELATED TO KINASES

IPC classification:
A61P 35/00, A61K 31/427, C07D 417/14, C07D 209/34, C07D 417/02
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION IN PROGRESS
EP14786138

DEVICE

IPC classification:
A61F 13/00, A61F 13/02
Agent:
Kevin John Cordina, Simmons & Simmons LLP
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14786137

DEVICE

IPC classification:
A61F 13/00, A61F 13/02
Agent:
Kevin John Cordina, Simmons & Simmons LLP
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14851643

RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

IPC classification:
A61K 31/436
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14854407

GENETIC MARKERS FOR ANTIPSYCHOTIC INDUCED WEIGHT GAIN AND METHODS FOR USE THEREOF

IPC classification:
G01N 33/48, C40B 40/10, C40B 40/06, C40B 30/04, C07H 21/00, C12Q 1/68
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14853689

FORMULATIONS AND METHODS FOR INCREASING OR REDUCING MUCUS

IPC classification:
A61B 17/00
Agent:
Catherine Louise Booth, Mathys & Squire LLP
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP16156278

NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT

IPC classification:
A61P 35/00, A61K 38/17, A61K 31/55, A61K 31/505
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14863430

TEMPORAL PEDIATRIC SEPSIS BIOMARKER RISK MODEL

IPC classification:
C12Q 1/68
Applicant:
Children's National Medical Center
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14873830

GENETIC MARKERS ASSOCIATED WITH SUICIDE RISK AND METHODS OF USE THEREOF

IPC classification:
G06F 19/18, C40B 40/06, C40B 30/04, C07H 21/04, C12Q 1/68
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14877182

GENETIC RECOMBINANT SACCHAROMYCES CEREVISIAE CAPABLE OF DEGRADING AND UTILIZING KITCHEN WASTES

IPC classification:
C12R 1/865, C12N 15/81, C12N 1/19
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14876437

THE USE OF TRANSGENIC PLANT FOR RECOVERY OF NON-TRANSGENIC HYBRIDS

IPC classification:
A01H 5/10, A01H 5/00
Applicant:
Public Higher Education in Rhode Island
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
APPLICATION WITHDRAWN
EP15740043

APILIMOD COMPOSITIONS AND METHODS FOR USING SAME

IPC classification:
A61K 31/5377, A61K 31/496, A61K 31/429
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15740722

NOVEL METHODS FOR TREATING CANCER

IPC classification:
C07D 417/14, A61P 35/00, A61K 31/427
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Donal Morgan Kelly, F. R. Kelly & Co.
Status:
EXAMINATION REQUESTED
EP15746714

3-SUBSTITUTED CARBONYL-NAPHTHO[2,3-B]FURANE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

IPC classification:
A01N 47/10
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Donal Morgan Kelly, F. R. Kelly & Co.
Status:
EXAMINATION REQUESTED
EP15706986

RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

IPC classification:
A61K 31/70, A61K 31/436, A61K 9/12, A61K 9/00, A61K 47/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP16182813

NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS

IPC classification:
A61P 35/00, A61K 31/35, A01N 43/16
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
The patent has been granted
EP15754639

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF ANTIPSYCHOTIC MEDICATION-INDUCED WEIGHT GAIN

IPC classification:
G06F 19/18, G06F 19/10, G01N 33/50, C12Q 1/68, G06F 19/12
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15707526

METHODS AND COMPOSITIONS FOR PERSONALIZED PAIN MANAGEMENT

IPC classification:
C12Q 1/68
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15740755

O-PHENYL CHALCONE COMPOUND AND PREPARATION METHOD AND USE THEREOF

IPC classification:
A61P 35/00, C07C 253/30, C07F 9/12, C07C 49/835, C07C 49/84, C07C 45/45, C07C 221/00, C07C 225/22, C07F 5/02
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15761005

ASYMMETRIC INTERFERING RNA COMPOSITIONS THAT SILENCE K-RAS AND METHODS OF USES THEREOF

IPC classification:
C12N 15/00, C07H 21/04, C07H 21/02
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Donal Morgan Kelly, F. R. Kelly & Co.
Status:
EXAMINATION REQUESTED
EP15772788

NEW TRICYCLIC QUINONE DERIVATIVE

IPC classification:
C07D 495/04, A61P 35/02, A61P 35/00, A61K 31/5377, A61K 31/4365, A61K 31/4355, A61K 31/381, C07D 491/048
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15718687

AN INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS

IPC classification:
A61P 43/00, A61K 31/436, A61K 9/14, A61K 9/72
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15828951

DIAGNOSTIC METHOD FOR DISTINGUISHING FORMS OF ESOPHAGEAL EOSINOPHILIA

IPC classification:
C08K 5/521, C08K 7/06, C08L 69/00, G01N 33/53, C12Q 1/68
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15836301

COMPOSITION AND MEDICINAL PRODUCT FOR REDUCING BODY WEIGHT AND BODY FAT, AND USE OF SAID PRODUCT

IPC classification:
A61P 3/04, A61K 31/05, A61K 36/82, A61K 36/9066
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15836003

COMPOSITION FOR REDUCING LOCAL FAT AND BODY WEIGHT, AND PHARMACEUTICALS AND USE THEREOF

IPC classification:
A61P 3/04, A61K 9/70, A61K 9/06, A61K 9/08, A61K 36/9066, A61K 31/05
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15787076

AN INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION

IPC classification:
A61K 9/12, A61P 11/00, A61P 9/12, A61K 31/557, A61K 31/436, A61K 9/00, A61K 45/06
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
Request for examination was made
EP16723855

METHODS FOR TREATING CANCER

IPC classification:
A61P 35/00, A61K 39/395, A61K 31/343
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
F. R. Kelly & Co.
Status:
Request for examination was made
EP16724491

METHODS FOR TREATING CANCER

IPC classification:
A61K 31/522, A61K 31/513, A61K 31/437, A61P 35/00, A61K 31/343
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
F. R. Kelly & Co.
Status:
Request for examination was made
EP16723854

METHODS FOR TREATING CANCER

IPC classification:
A61K 31/337, A61P 35/00, A61K 39/395, A61K 31/343
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
F. R. Kelly & Co.
Status:
Request for examination was made
EP16725260

METHODS FOR TREATING CANCER WITH A STAT3 PATHWAY INHIBITOR AND KINASE INHIBITOR

IPC classification:
A61P 35/00, A61K 31/427, A61K 31/343
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
F. R. Kelly & Co.
Status:
Request for examination was made
EP16729734

COMPOSITIONS COMPRISING A CANCER STEMNESS INHIBITOR AND AN IMMUNOTHERAPEUTIC AGENT FOR USE IN TREATING CANCER

IPC classification:
A61P 37/04, A61P 35/04, A61P 35/00, A61K 31/00, A61K 39/395, A61K 31/343
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
F. R. Kelly & Co.
Status:
Request for examination was made
EP18154283

METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY

IPC classification:
A61K 31/00, A61P 9/04, A61K 31/497
Applicant:
University of Hawaii - Office of Technology Transfer & Economic Development
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
The application has been published

Please Sign in to use this feature